THERAPEUTICS

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

  1. K. Reich1,
  2. A.D. Burden2,
  3. J.N. Eaton3,
  4. N.S. Hawkins3

Article first published online: 11 NOV 2011

DOI: 10.1111/j.1365-2133.2011.10583.x

Issue

British Journal of Dermatology

British Journal of Dermatology

Volume 166, Issue 1, pages 179–188, January 2012

Additional Information

How to Cite

Reich, K., Burden, A.D., Eaton, J.N. and Hawkins, N.S. (2012), Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology, 166: 179–188. doi: 10.1111/j.1365-2133.2011.10583.x

Author Information

  1. 1

    Dermatologikum Hamburg, Drehbahn 1-3, 20354 Hamburg, Germany

  2. 2

    Department of Dermatology, Western Infirmary, Glasgow G11 6NT, U.K.

  3. 3

    Health Economics, Oxford Outcomes, Seacourt Tower, West Way, Oxford, OX2 0JJ, U.K.

*James Eaton. E-mail: james.eaton@oxfordoutcomes.com

  1. Funding sources This study has been funded by Janssen-Cilag Ltd. but no restrictions have been placed on the design or results of the analysis. The authors take full responsibility for the contents of the manuscript.

  2. Conflicts of interest KR has served as consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott, Biogen Idec, Celgene, Centocor, Janssen-Cilag, Leo, Medac, Merck, MSD (formerly Essex, Schering-Plough), Novartis, Pfizer (formerly Wyeth). ADB has acted as lecturer, consultant and researcher for Abbott, Janssen, Leo, MSD, Novartis and Pfizer. JNE and NSH work for an international consultancy and as such have received funding from numerous device and and pharmaceutical companies to conduct studies similar to that presented in this paper.

Publication History

  1. Issue published online: 27 DEC 2011
  2. Article first published online: 11 NOV 2011
  3. Accepted manuscript online: 12 SEP 2011 05:50PM EST
  4. Accepted for publication 14 August 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (268K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (268K)